Imagion Biosystems Ltd (IBX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 84 | -190 | -507 | -219 | -8 |
| Other Investing Activity | 0 | 0 | 39 | -91 | 0 |
| Investing Cash Flow | $84 | $-190 | $-469 | $-310 | $-8 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 234 |
| Debt Repayment | 720 | 3,500 | N/A | N/A | N/A |
| Common Stock Issued | 3,125 | 2,383 | 3 | 5,511 | 16,108 |
| Common Stock Repurchased | N/A | N/A | N/A | -6 | -1,340 |
| Other Financing Activity | -235 | -1,591 | -965 | -359 | -481 |
| Financing Cash Flow | $3,610 | $4,292 | $-962 | $5,146 | $14,521 |
| Exchange Rate Effect | 20 | -4 | 557 | 426 | -91 |
| Beginning Cash Position | 227 | 4,446 | 13,394 | 13,201 | 3,402 |
| End Cash Position | 2,671 | 227 | 4,446 | 13,394 | 13,201 |
| Net Cash Flow | $2,423 | $-4,215 | $-9,505 | $-233 | $9,890 |
| Free Cash Flow | |||||
| Capital Expenditure | N/A | -190 | -507 | -219 | -8 |
| Free Cash Flow | 0 | -190 | -507 | -219 | -8 |